Biolinq company information, Employees & Contact Information

Diabetes Dialogue: Biolinq Shine, Insulin Icodec, and Eli Lilly's Pipeline HCPLive

Biolinq's color-coded glucose sensor patch nets FDA clearance Fierce Biotech

Biolinq gets FDA de novo nod for intradermal glucose sensor MedTech Dive

Biolinq Shine™ Granted De Novo Classification by U.S. FDA GlobeNewswire

Biolinq Shine Receives FDA De Novo Classification as First Multianalyte Wearable for Type 2 Diabetes Pharmacy Times

Biolinq’s multi-function biosensor receives FDA De Novo Classification HME News

Biolinq Announces Close of $100M Series C Financing to Advance Its Biowearable Platform for Metabolic Health Business Wire

Biolinq raises $100M for intradermal glucose sensor for type 2 diabetes Mobi Health News

Biolinq bags FDA okay for autonomous glucose sensor pharmaphorum

Study backs Biolinq intradermal sensor in muscle loss prevention during GLP-1 therapy Drug Delivery Business

Biolinq wins FDA de novo nod for autonomous, needle-free CGM MassDevice

ADA25: Biolinq biosensor could track muscle loss during GLP-1 treatment FirstWord Pharma

FDA grants De Novo classification to first needle-free, glucose sensor Biolinq Shine Indian Pharma Post

Biolinq raises $100M to carry glucose sensor patch across the finish line Fierce Biotech

Biolinq closes $100M Series C funding round for biosensor platform Drug Delivery Business

Biolinq granted de novo classification for needle-free glucose monitor Medical Device Network

Investors Put $58 Million Into Biolinq’s Push for Easier Glucose-Monitoring The Wall Street Journal

Biolinq Snags $58M for ‘Smallest Biosensor in the World’ MedCity News

Biolinq Levels Up with $100M Series C Financing Medical Device and Diagnostic industry

Biolinq’s Jared Tangney on making CGMs unintimidating MedTech Dive

Biolinq raises $100m to support US launch of intradermal glucose sensor Medical Device Network

Biolinq Secures $100M Series C to Support Regulatory Path for Glucose Monitoring Wearable The Healthcare Technology Report.

Amalgam Rx Partners with Biolinq -- Lighting Pathways to Better Health Business Wire

Biolinq Raises $58M San Diego Business Journal

Biolinq Lands $100M To Propel Glucose-Tracking Wearable Athletech News

Could Biolinq’s Patch Change the Game for CGMs? Medical Device and Diagnostic industry

Biolinq Aims To ‘Shine’ In Early 2026 With Needle-Free CGM US Debut, Human Data On Protein Sensor Citeline News & Insights

Biolinq Shine Receives FDA Clearance as First Needle-Free Glucose Sensor - DSM Diabetes Self-Management

Biolinq Raises $58 Million to Advance Wearable Biosensors Through Pivotal Trial for Metabolic Health Using Precision Microsensor Technology Business Wire

Health-tech startup raises $100M Axios

Biolinq raises $58m for glucose microsensor pivotal trial Medical Device Network

Biolinq Raises $58M for Noninvasive Glucose Sensor Fitt Insider

Biolinq Raises $58M for Color-Coded Wearable Glucose Sensor Athletech News

Biolinq Secures $58M to Advance Continuous Glucose Monitoring Patch HIT Consultant

Biolinq: Less pain, $58M gain for tiny glucose sensor BioWorld MedTech

Biolinq raises $100M for glucose wearable for Type 2 diabetes Modern Healthcare News

Biolinq amasses $100M for its painless glucose sensor patch Fierce Biotech

Biolinq Aims To Transform Diabetic Glucose Monitoring With Needle-Free Patch Citeline News & Insights

Biolinq names new CEO Drug Delivery Business

Biolinq Lands $100M For its Glucose Monitoring Patch Fitt Insider

Biolinq Raises $100 Million in Series B San Diego Business Journal

Biolinq raises an extra $4.75M in series A for trials of its painless diabetes sensor Fierce Biotech

Minimally Invasive CGM company Biolinq raises $10 million in Series A funding Mobi Health News